ICR Logo
Donate
    •
  • Research and discoveries
  • Find a researcher
  • ICR divisions
  • Centres and strategic collaborations
  • Our facilities and technology
  • Research by cancer type
  • Cancer discovery news
  • Cancer blogs
  • Animal research
  • Our research achievements
    • ICR divisions Breast Cancer Research Cancer Biology Cancer Therapeutics Cell and Molecular Biology Clinical Studies Genetics and Epidemiology Radiotherapy and Imaging Structural Biology
    Our facilities and technology Baculovirus Facility Light Microscopy Facility Electron Microscopy Facility Flow Cytometry Facility Mechanical Workshop and 3D Printing Proteomics Core Facility Scientific Computing Service Genomics Facility X-ray Crystallography Facility Chelsea Biophysics Facility Correlative Light and Electron Microscopy (CLEM) Lab Antibody Facility Sutton Pathology Facility
    Research by cancer type Bladder cancer Blood cancers Bone cancer Bowel cancer Brain cancer Breast cancer Cervical cancer Childhood cancers Gastrointestinal cancers Head and neck cancer Kidney cancer Lung cancer Melanoma Ovarian cancer Pancreatic cancer Prostate cancer Sarcoma
    Cancer blogs Research blogs The Darwin Cancer Blog
    Our research achievements Characterising the BRAF gene Transforming prostate cancer treatment Advanced radiotherapy techniques Identifying a breast cancer gene Targeting Hsp90 How cells become cancerous The function of the thymus Practice changing clinical trials in radiotherapy and imaging DNA damage and cancer Identifying cancer predisposition genes Applying evolutionary biology to cancer Transforming treatment for the most common type of breast cancer Developing the Pharmacological Audit Trail Discovering early chemotherapy drugs Discovering and developing a leading PI3K inhibitor Applying genetic principles to treatment of BRCA-mutant cancers Carcinogens in cigarette smoke
  • Study and careers
  • PhDs for science graduates
  • Opportunities for clinicians
  • Student life and support
  • Undergraduate Summer Scholarship Scheme
  • Support moving to the UK
  • Careers at the ICR
  • Working life and benefits
    • PhDs for science graduates Our PhD projects Our PhD application process Black Leaders in Cancer & Convergence PhD Studentships PhD FAQs and funding Contact student admissions PhDs and training news
    Opportunities for clinicians MSc in Oncology PhD and MD(Res) for clinicians NIHR academic training Radiotherapy and imaging training courses Opportunities for postdoctoral clinical fellows
    Student life and support Tuition fees Accommodation support Welfare Social life Academic and career support Student resources Student stories Alumni stories
    Undergraduate Summer Scholarship Scheme How to apply FAQs Research groups
    Careers at the ICR Postdocs Research scientists and scientific support Group leaders Clinicians Professional Service roles Contact our career faculty Apprenticeships
    Working life and benefits Staff benefits World-leading working facilities Equality and social groups Career development Employee stories
  • Industry partnerships
  • Partnership opportunities
  • Consultancy in oncology
  • Why partner with us
  • Our therapeutic pipeline
  • London Cancer Hub
  • Contact our partner team
    • Why partner with us Our partnership philosophy The Innovation Gateway Entrepreneurs-in-residence Spin-out companies Enterprise events Our treatment and technology successes
  • About us
  • Our strategy 
  • Our values
  • Leadership and governance
  • ICR and The Royal Marsden
  • ICR news
  • Patient stories
  • Public engagement and schools outreach
  • Advocacy engagement: policy and public affairs
  • Funding and spending
  • Contact us
    • Our values Sustainability Equality and diversity Policies and responsibilities
    Leadership and governance Our leadership team Executive board Board of trustees Corporate governance ICR committees
    Public engagement and schools outreach Resources for schools Public engagement strategy Public events Our Engagement Stories
    Advocacy engagement: policy and public affairs Our policy priorities Creating a sustainable funding model for research in universities Encouraging international talent to support cancer research Joining up the clinical research pipeline Improving access to clinical trials
  • Support us
  • Making a donation
  • Fundraising
  • Leave a legacy
  • Philanthropy
  • Corporate partnerships
  • Charity partners
  • Our appeals
  • Search newsletter
    • Making a donation Why donate to the ICR How is my money spent Contact our donations team Payroll giving Gift Aid
    Fundraising How to fundraise with us Sport events and challenges Fundraising news Supporter stories Share your story Volunteer at our events
    Leave a legacy Create a Will for free Donate in memory Information for executors The National Free Wills Network Meet our Legacy Officers
    Our appeals Help every man with prostate cancer Help us outsmart melanoma Defeat blood cancer Help more women survive cancer Childhood cancers Combination treatments Monthly gift for cancer patients 
    Research and discoveries
    Study and careers
    Industry partnerships
    About us
    Support us
    See all hubs

    Research and discoveries

    Find a researcher
    ICR divisions
    Centres and strategic collaborations
    Our facilities and technology
    Research by cancer type
    Cancer discovery news
    Cancer blogs
    Animal research
    Our research achievements
    See all hubs

    Study and careers

    PhDs for science graduates
    Opportunities for clinicians
    Student life and support
    Undergraduate Summer Scholarship Scheme
    Support moving to the UK
    Careers at the ICR
    Working life and benefits
    See all hubs

    Industry partnerships

    Partnership opportunities
    Consultancy in oncology
    Why partner with us
    Our therapeutic pipeline
    London Cancer Hub
    Contact our partner team
    See all hubs

    About us

    Our strategy 
    Our values
    Leadership and governance
    ICR and The Royal Marsden
    ICR news
    Patient stories
    Public engagement and schools outreach
    Advocacy engagement: policy and public affairs
    Funding and spending
    Contact us
    See all hubs

    Support us

    Making a donation
    Fundraising
    Leave a legacy
    Philanthropy
    Corporate partnerships
    Charity partners
    Our appeals
    Search newsletter
    See Research and discoveries

    Find a researcher

    Publications
    See Research and discoveries

    ICR divisions

    Breast Cancer Research
    Cancer Biology
    Cancer Therapeutics
    Cell and Molecular Biology
    Clinical Studies
    Genetics and Epidemiology
    Radiotherapy and Imaging
    Structural Biology
    See Research and discoveries

    Our facilities and technology

    Baculovirus Facility
    Light Microscopy Facility
    Electron Microscopy Facility
    Flow Cytometry Facility
    Mechanical Workshop and 3D Printing
    Proteomics Core Facility
    Scientific Computing Service
    Genomics Facility
    X-ray Crystallography Facility
    Chelsea Biophysics Facility
    Correlative Light and Electron Microscopy (CLEM) Lab
    Antibody Facility
    Sutton Pathology Facility
    See Research and discoveries

    Research by cancer type

    Bladder cancer
    Blood cancers
    Bone cancer
    Bowel cancer
    Brain cancer
    Breast cancer
    Cervical cancer
    Childhood cancers
    Gastrointestinal cancers
    Head and neck cancer
    Kidney cancer
    Lung cancer
    Melanoma
    Ovarian cancer
    Pancreatic cancer
    Prostate cancer
    Sarcoma
    See Research and discoveries

    Cancer discovery news

    Media office
    See Research and discoveries

    Cancer blogs

    Research blogs
    The Darwin Cancer Blog
    See Research and discoveries

    Our research achievements

    Characterising the BRAF gene
    Transforming prostate cancer treatment
    Advanced radiotherapy techniques
    Identifying a breast cancer gene
    Targeting Hsp90
    How cells become cancerous
    The function of the thymus
    Practice changing clinical trials in radiotherapy and imaging
    DNA damage and cancer
    Identifying cancer predisposition genes
    Applying evolutionary biology to cancer
    Transforming treatment for the most common type of breast cancer
    Developing the Pharmacological Audit Trail
    Discovering early chemotherapy drugs
    Discovering and developing a leading PI3K inhibitor
    Applying genetic principles to treatment of BRCA-mutant cancers
    Carcinogens in cigarette smoke
    See Study and careers

    PhDs for science graduates

    Our PhD projects
    Our PhD application process
    Black Leaders in Cancer & Convergence PhD Studentships
    PhD FAQs and funding
    Contact student admissions
    PhDs and training news
    See Study and careers

    Opportunities for clinicians

    MSc in Oncology
    PhD and MD(Res) for clinicians
    NIHR academic training
    Radiotherapy and imaging training courses
    Opportunities for postdoctoral clinical fellows
    See Study and careers

    Student life and support

    Tuition fees
    Accommodation support
    Welfare
    Social life
    Academic and career support
    Student resources
    Student stories
    Alumni stories
    See Study and careers

    Undergraduate Summer Scholarship Scheme

    How to apply
    FAQs
    Research groups
    See Study and careers

    Careers at the ICR

    Postdocs
    Research scientists and scientific support
    Group leaders
    Clinicians
    Professional Service roles
    Contact our career faculty
    Apprenticeships
    See Study and careers

    Working life and benefits

    Staff benefits
    World-leading working facilities
    Equality and social groups
    Career development
    Employee stories
    See Industry partnerships

    Why partner with us

    Our partnership philosophy
    The Innovation Gateway
    Entrepreneurs-in-residence
    Spin-out companies
    Enterprise events
    Our treatment and technology successes
    See Industry partnerships

    Contact our partner team

    Connections newsletter
    See About us

    Our strategy 

    Strategic partners
    See About us

    Our values

    Sustainability
    Equality and diversity
    Policies and responsibilities
    See About us

    Leadership and governance

    Our leadership team
    Executive board
    Board of trustees
    Corporate governance
    ICR committees
    See About us

    Public engagement and schools outreach

    Resources for schools
    Public engagement strategy
    Public events
    Our Engagement Stories
    See About us

    Advocacy engagement: policy and public affairs

    Our policy priorities
    Creating a sustainable funding model for research in universities
    Encouraging international talent to support cancer research
    Joining up the clinical research pipeline
    Improving access to clinical trials
    See Support us

    Making a donation

    Why donate to the ICR
    How is my money spent
    Contact our donations team
    Payroll giving
    Gift Aid
    See Support us

    Fundraising

    How to fundraise with us
    Sport events and challenges
    Fundraising news
    Supporter stories
    Share your story
    Volunteer at our events
    See Support us

    Leave a legacy

    Create a Will for free
    Donate in memory
    Information for executors
    The National Free Wills Network
    Meet our Legacy Officers
    See Support us

    Philanthropy

    Trusts and Foundations
    See Support us

    Corporate partnerships

    Corporate partnership highlights
    See Support us

    Our appeals

    Help every man with prostate cancer
    Help us outsmart melanoma
    Defeat blood cancer
    Help more women survive cancer
    Childhood cancers
    Combination treatments
    Monthly gift for cancer patients 
    • Research and discoveries
      • Find a researcher
        • Publications
      • ICR divisions
        • Breast Cancer Research
          • Breast Cancer Clinical Research
          • Breast Cancer Immunology
          • Breast Cancer Data Science Group
          • Breast Cancer Systemic Therapy Trials
          • Breast Epigenetic Plasticity and Evolution
          • Breast Surgery Outcome Measures
          • Cancer Dynamics
          • Cancer Stem Cell
          • Cell Death and Immunity
          • Cytoskeleton and Cancer Metastasis
          • Endocrine Control Mechanisms
          • Endocrine Therapy Resistance
          • Functional Genetic Epidemiology
          • Functional Genomics
          • Functional Tumour Immunology
          • Molecular Cell Biology
          • Precision Oncology
          • Molecular Oncology
          • Target Validation and Genome Stability Group
        • Cancer Biology
          • Tumour Functional Heterogeneity
          • Systems and Precision Cancer Medicine Team
          • Sarcoma Molecular Pathology
          • Preclinical Modelling of Paediatric Cancer Evolution
          • Molecular and Systems Oncology Team
          • Lymphoma biology and imaging
          • Integrated Pathology
          • Haemato-Oncology
          • Glioma
          • Genomics and Evolutionary Dynamics
          • Evolutionary Immunogenomics
          • Computational Pathology and Integrative Genomics
          • Chronic Lymphoid malignancies: Clinical Trials and Translational Research (El-Sharkawi)
          • Biology of Childhood Leukaemia
          • Acute Leukaemia Team
          • Paediatric Stem Cell Transplant
          • Thoracic Oncology Immunotherapy
        • Cancer Therapeutics
          • Targeted Protein Degradation
          • Target Evaluation and Molecular Therapeutics
          • Signal Transduction and Molecular Pharmacology
          • RNA Biology and Molecular Therapeutics
          • Myeloma Biology and Therapeutics
          • Medicinal Chemistry 4 (including Analytical Chemistry)
          • Medicinal Chemistry 1
          • Clinical Pharmacology & Trials (including Drug Metabolism and Pharmacokinetics Group)
          • Chromosomal Translocations and Intracellular Antibody Therapeutics
          • Clinical Pharmacology Adaptive Therapy
          • Tumour Microenvironment and Pharmacology
          • Clinical Pharmacodynamics Biomarker
          • Cancer Biomarkers
          • Medicinal Chemistry 3
          • Hit Discovery and Structural Design
          • Induced Proximity Therapeutics 
        • Cell and Molecular Biology
          • Telomere Biology
          • Structural Biology of Cell Signalling
          • Signalling and Cancer Metabolism
          • Post-translational Modifications and Cell Proliferation
          • Genome Stability and Innate Immunity
          • Genome Replication
          • Genome Instability and Cancer
          • Functional Proteomics
          • Epigenetics and Genome Stability
          • Epigenetics and Cancer
          • Dynamical Cell Systems
            • PhenoPlot
          • Development and Cancer
          • Chromatin Biology
          • Cell Division
        • Clinical Studies
          • Translational Therapeutics
          • Thoracic Oncology
          • Sarcoma Clinical Trials and Translational Research
          • Sarcoma Clinical Trials in Children and Young People
          • Paediatric & Adolescent Neuro-Oncology and Drug Development (Carceller)
          • Melanoma and Kidney Cancer Group
          • The Adult Drug Development Unit at the ICR and the RM
            • Our research at the DDU
          • ICR-CTSU Radiotherapy, Urology and Head and Neck Cancers Trials
          • ICR-CTSU Integrative Genomic Analysis in Clinical Trials
          • ICR-CTSU Early Phase and Adaptive Trials
            • The OPTIMISE-AR project
            • The DEFINE study SPIRIT and CONSORT extensions
          • ICR-CTSU Breast and Rare Cancers Trials
          • Gynaecological Oncology Surgery
          • Gynaecological Cancers (Systemic Therapy and Clinical Trials)
          • Developmental Oncology
          • Cancer Biomarkers
          • Prostate Cancer Targeted Therapy Group
          • Paediatric Solid Tumour Biology and Therapeutics
          • ICR-CTSU Gynaecological Cancers Trials and Imaging studies
        • Genetics and Epidemiology
          • Translational Genetics
          • Oncogenetics
            • IMPACT
            • PMPRC
            • PRACTICAL
            • UK Genetic Prostate Cancer Study
            • The PROFILE Study
            • GENPROS
            • GENPET
            • BARCODE 1
            • BARCODE 2
            • PRODICT Study
          • Myeloma Molecular Therapy
          • Integrative Cancer Epidemiology
          • Clinical Cancer Epidemiology
          • Cancer Genomics
            • PICS Database
            • SNPLINK Database
            • National Study of Colorectal Cancer Genetics (NSCCG)
            • FCLL study
            • National Brain Tumour (NBT) study
            • TRANSORCE study
        • Radiotherapy and Imaging
          • Uro-oncology clinical trials
          • Ultrasound and Optical Imaging
          • Translational Therapeutic Radiography
          • Translational Sarcoma, Melanoma and Rare Tumour Surgery
          • Translational Immunotherapy
          • Translational Breast Radiobiology
          • Targeted Therapy Group
          • Stereotactic and Precision Radiotherapy
          • Sarcoma and Melanoma Surgery
          • Radiation-enhanced Immunotherapy
          • Radiotherapy Physics Modelling
          • Radioisotope Physics
          • Quantitative Biomedical Imaging
          • Prostate and Bladder Cancer Research
            • PureGym Prostate Cancer Initiative
          • Pre-Clinical MRI
          • Preclinical Molecular Imaging
          • Magnetic Resonance Imaging in Radiotherapy
          • Oncogenetics
          • Clinical Academic Radiotherapy Team (Huddart)
          • Functional Imaging Group
          • Imaging for Radiotherapy Adaptation Team
          • Breast Cancer Radiotherapy
          • Magnetic Resonance
          • Therapeutic Ultrasound
          • Multimodality Molecular Imaging
          • Gastrointestinal Clinical Oncology
          • Computational Imaging
          • Evolution and Translational Genomics
          • Experimental and Translational Theranostic
          • Stromal Radiobiology
        • Structural Biology
          • Structural Biology of DNA Repair Complexes
          • Structural Biology of Cell Signalling
          • Molecular Mechanisms of Cell Cycle Regulation
          • Mechanisms and Regulation of pre-mRNA Splicing
          • Macromolecular Structural Biology Team
      • Centres and strategic collaborations
      • Our facilities and technology
        • Baculovirus Facility
        • Light Microscopy Facility
        • Electron Microscopy Facility
        • Flow Cytometry Facility
        • Mechanical Workshop and 3D Printing
        • Proteomics Core Facility
        • Scientific Computing Service
        • Genomics Facility
        • X-ray Crystallography Facility
        • Chelsea Biophysics Facility
        • Correlative Light and Electron Microscopy (CLEM) Lab
        • Antibody Facility
        • Sutton Pathology Facility
      • Research by cancer type
        • Bladder cancer
        • Blood cancers
          • Timeline: our research into leukaemia
          • Timeline: our research into myeloma
        • Bone cancer
        • Bowel cancer
        • Brain cancer
        • Breast cancer
        • Cervical cancer
        • Childhood cancers
          • Timeline: our research into childhood cancer
        • Gastrointestinal cancers
        • Head and neck cancer
        • Kidney cancer
        • Lung cancer
        • Melanoma
        • Ovarian cancer
        • Pancreatic cancer
        • Prostate cancer
          • Timeline: our research into prostate cancer
        • Sarcoma
      • Cancer discovery news
        • Media office
      • Cancer blogs
        • Research blogs
        • The Darwin Cancer Blog
      • Animal research
      • Our research achievements
        • Characterising the BRAF gene
        • Transforming prostate cancer treatment
        • Advanced radiotherapy techniques
        • Identifying a breast cancer gene
        • Targeting Hsp90
        • How cells become cancerous
        • The function of the thymus
        • Practice changing clinical trials in radiotherapy and imaging
        • DNA damage and cancer
        • Identifying cancer predisposition genes
        • Applying evolutionary biology to cancer
        • Transforming treatment for the most common type of breast cancer
        • Developing the Pharmacological Audit Trail
        • Discovering early chemotherapy drugs
        • Discovering and developing a leading PI3K inhibitor
        • Applying genetic principles to treatment of BRCA-mutant cancers
        • Carcinogens in cigarette smoke
    • Study and careers
      • PhDs for science graduates
        • Our PhD projects
          • PhD project archive
        • Our PhD application process
        • Black Leaders in Cancer & Convergence PhD Studentships
        • PhD FAQs and funding
        • Contact student admissions
        • PhDs and training news
      • Opportunities for clinicians
        • MSc in Oncology
          • Course essentials
        • PhD and MD(Res) for clinicians
          • Clinical PhDs
          • Course essentials
        • NIHR academic training
        • Radiotherapy and imaging training courses
          • Radioactive waste advisers training course
          • Nuclear medicine and PET imaging course
          • Magnetic resonance imaging (MRI) and spectroscopy course
          • Physics of medical imaging courses
          • Image Guided and Adaptive Radiotherapy in Clinical Practice: Including SABR Topics
          • Radiation Protection Training Course
          • Practical and Theoretical Radiotherapy Physics Courses
            • Practical and Theoretical Radiotherapy Physics Courses - Application form
          • Diagnostic radiology & CT course
          • Ultrasound imaging course
          • Image theory, perception and processing course
          • Magnetic Resonance Image Guided Radiotherapy (MRIgRT)
        • Opportunities for postdoctoral clinical fellows
      • Student life and support
        • Tuition fees
        • Accommodation support
          • Rent guarantor scheme
        • Welfare
        • Social life
        • Academic and career support
          • Alumni, careers and destinations
        • Student resources
          • Library and E-learning
        • Student stories
        • Alumni stories
      • Undergraduate Summer Scholarship Scheme
        • How to apply
        • FAQs
        • Research groups
      • Support moving to the UK
      • Careers at the ICR
        • Postdocs
        • Research scientists and scientific support
        • Group leaders
        • Clinicians
        • Professional Service roles
        • Contact our career faculty
        • Apprenticeships
          • Scientific Apprenticeship Conference 
      • Working life and benefits
        • Staff benefits
        • World-leading working facilities
        • Equality and social groups
        • Career development
        • Employee stories
    • Industry partnerships
      • Partnership opportunities
      • Consultancy in oncology
      • Why partner with us
        • Our partnership philosophy
        • The Innovation Gateway
        • Entrepreneurs-in-residence
        • Spin-out companies
        • Enterprise events
        • Our treatment and technology successes
      • Our therapeutic pipeline
      • London Cancer Hub
      • Contact our partner team
        • Connections newsletter
    • About us
      • Our strategy 
        • Strategic partners
      • Our values
        • Sustainability
        • Equality and diversity
        • Policies and responsibilities
      • Leadership and governance
        • Our leadership team
        • Executive board
        • Board of trustees
        • Corporate governance
        • ICR committees
      • ICR and The Royal Marsden
      • ICR news
      • Patient stories
      • Public engagement and schools outreach
        • Resources for schools
        • Public engagement strategy
        • Public events
          • School Events Request Form
        • Our Engagement Stories
      • Advocacy engagement: policy and public affairs
        • Our policy priorities
        • Creating a sustainable funding model for research in universities
        • Encouraging international talent to support cancer research
        • Joining up the clinical research pipeline
        • Improving access to clinical trials
      • Funding and spending
      • Contact us
    • Support us
      • Making a donation
        • Why donate to the ICR
        • How is my money spent
        • Contact our donations team
        • Payroll giving
        • Gift Aid
      • Fundraising
        • How to fundraise with us
          • How to fundraise with us (Thank you)
        • Sport events and challenges
          • London Marathon 2026
        • Fundraising news
        • Supporter stories
        • Share your story
        • Volunteer at our events
      • Leave a legacy
        • Create a Will for free
          • Legacy support FAQs
          • Solicitor FAQs
          • Will for free programme members
        • Donate in memory
        • Information for executors
        • The National Free Wills Network
        • Meet our Legacy Officers
      • Philanthropy
        • Trusts and Foundations
      • Corporate partnerships
        • Corporate partnership highlights
      • Charity partners
      • Our appeals
        • Help every man with prostate cancer
        • Help us outsmart melanoma
        • Defeat blood cancer
        • Help more women survive cancer
        • Childhood cancers
        • Combination treatments
        • Monthly gift for cancer patients 
      • Search newsletter
    • Contact us
    • Register my fundraising event
    • Subscribe to Search Newsletter
    • Subscribe to Phd opportunities
    • Contact the Development office
    • Complete a gift aid declaration
    • Request a Breakthrough Generations pack
    • Contact the Registry team
    • member-gate
    ICR Logo
    • Research and discoveries
    • Study and careers
    • Industry partnerships
    • About us
    • Support us
    • Contact us
    • Privacy
    • Terms and conditions
    • Accessibility
    • Purchasing
    • Conflict of interest in research
    • Annual remuneration statement
    • Sustainability
    • Modern slavery statement
    • Cookies

    Copyright © 2026 The Institute of Cancer Research.

    All rights reserved. Registered office: The Institute of Cancer Research, 123 Old Brompton Road, London, SW7 3RP. A Charity, Not for Profit. Company Limited by Guarantee.
    Registered in England No. 534147. VAT Registration No. GB 849 0581 02.